Monitoring Proteinuria in Patients with Lupus From the College | January 6, 2026 Both systemic lupus erythematosus and lupus nephritis reduce a person’s life expectancy, with SLE cutting an average of 12.4 years off a person’s life expectancy and lupus nephritis reducing life expectancy by another 2.7 years. Thus, the 2024 ACR Guideline for the Screening, Treatment, and Management of Patients with Lupus Nephritis suggests that patients with lupus but without known kidney disease should be screened for proteinuria, offering recommendations on frequency of testing. Review the guideline or take the quiz below. The 2024 ACR Guideline for the Screening, Treatment, and Management of Patients with Lupus Nephritis suggests that patients with lupus should be monitored for the development of proteinuria: A. Only when the patient experiences extra-renal flares B. Monthly C. Every three to six months D. Every six to 12 months None Time's up
